RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.


Ahead of Kigali Summit, RTI International commits to continuing the fight against NTDs and malaria

RESEARCH TRIANGLE PARK, N.C. — Ahead of the Kigali Summit on Malaria and Neglected Tropical Diseases (NTDs), RTI International has endorsed the Kigali Declaration on NTDs, building on a long-standing organizational dedication to ending NTDs worldwide. This follows RTI’s recent commitment to deliver $3 million in strategic investment funding for research that fills gaps in knowledge and ultimately accelerates global progress toward the control and elimination of NTDs.

The Kigali Declaration on NTDs is a high-level, political declaration that aims to mobilize political will and secure commitments to achieve the Sustainable Development Goal 3 (SDG3) target on NTDs and to deliver the targets set out in the World Health Organization’s Neglected Tropical Disease Roadmap (2021-2030).

"RTI is proud to reaffirm our more than 15-year commitment to ending NTDs globally," said RTI president and CEO Tim J. Gabel. "Through our NTD work, including supporting health ministries to deliver more than 2 billion treatments to date, we actively live our mission to improve the human condition by turning knowledge into practice." 

On June 23, heads of state, CEOs and global leaders will gather at the Kigali Summit alongside the 26th Commonwealth Heads of Government Meeting (CHOGM). The summit is a catalyzing moment for world leaders to reaffirm commitments to end malaria and NTDs — diseases that impact billions of people around the world.

“We are committed to ending malaria and NTDs and join global partners in calling for continued investment in combatting these infectious diseases,” said Hala AlMossawi, Vice President for Global Health at RTI. “By ending these diseases, we can build more resilient health systems, unlock economic growth and human potential, and ensure a safer world for everyone.”

For more than 15 years, RTI has supported health ministries in delivering successful, cost-effective, and sustainable efforts to end NTDs. RTI has led USAID’s global flagship NTD programs and partnered with a variety of multilateral and private donors to reach over 80 countries with training, technical support and resources to improve the impact and effectiveness of NTD programs. Together, these efforts have reached tremendous scale and impact, including delivering more than 2 billion treatments to more than 220 million people.

RTI is also a global leader in malaria prevention, control and elimination, having partnered with USAID and more than 20 governments to reach more than 87.5 million people with malaria education, prevention and treatment. To date, RTI has supported the distribution of more than 14 million bed nets, greatly reducing malaria prevalence in some areas and dramatically lowering malaria-related hospital admissions.

Learn more about RTI’s work in malaria and NTDs